Literature DB >> 9106171

Granulocyte-macrophage colony-stimulating factor and the immune system.

P E Tarr1.   

Abstract

Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a multifunctional cytokine currently used for the reversal of neutropenia associated with cytotoxic chemotherapy, bone marrow and haemopoietic stem cell transplantation. GM-CSF also modulates the function of differentiated white blood cells. In the context of local inflammatory responses, GM-CSF stimulates macrophages for antimicrobial and antitumor effects. GM-CSF further enhances healing and repair by its actions on fibroblasts and epidermal cells. GM-CSF is the pivotal mediator of the maturation and function of dendritic cells, the most important cell type for the induction of primary T cell immune responses. GM-CSF may enhance antibody dependent cellular cytotoxicity (ADCC) in several cell types, and the generation and cytotoxicity of natural killer (NK) cells. On this basis, GM-CSF may be useful for inducing or augmenting antibody responses to antimicrobial vaccines, to enhance killing of intracellular microorganisms, to accelerate epidermal and mucosal wound healing, and to stimulate protective immunity against tumors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9106171     DOI: 10.1007/bf02990841

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  90 in total

1.  A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides.

Authors:  R Suto; P K Srivastava
Journal:  Science       Date:  1995-09-15       Impact factor: 47.728

2.  Evaluation of tolerability and antibody response after recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) and a single dose of recombinant hepatitis B vaccine.

Authors:  P E Tarr; R Lin; E A Mueller; J M Kovarik; M Guillaume; T C Jones
Journal:  Vaccine       Date:  1996-09       Impact factor: 3.641

3.  New insights into the mobilization and phagocytic activity of dendritic cells.

Authors:  J M Austyn
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

4.  Granulocyte-macrophage colony-stimulating factor augmentation of T-cell receptor-dependent and T-cell receptor-independent thymocyte proliferation.

Authors:  A M Stewart-Akers; J S Cairns; D J Tweardy; S A McCarthy
Journal:  Blood       Date:  1994-02-01       Impact factor: 22.113

5.  Demonstration of a rational strategy for human prostate cancer gene therapy.

Authors:  M G Sanda; S R Ayyagari; E M Jaffee; J I Epstein; S L Clift; L K Cohen; G Dranoff; D M Pardoll; R C Mulligan; J W Simons
Journal:  J Urol       Date:  1994-03       Impact factor: 7.450

Review 6.  Future uses of granulocyte-macrophage colony-stimulating factor (GM-CSF).

Authors:  T C Jones
Journal:  Stem Cells       Date:  1994       Impact factor: 6.277

7.  Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages.

Authors:  C S Hsieh; S E Macatonia; C S Tripp; S F Wolf; A O'Garra; K M Murphy
Journal:  Science       Date:  1993-04-23       Impact factor: 47.728

8.  Involvement of very late activation antigen 4 (VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) in tumor necrosis factor alpha enhancement of experimental metastasis.

Authors:  H Okahara; H Yagita; K Miyake; K Okumura
Journal:  Cancer Res       Date:  1994-06-15       Impact factor: 12.701

9.  Granulocyte-macrophage colony-stimulating factor-induced antibody-dependent cellular cytotoxicity in bone marrow macrophages: application in bone marrow transplantation.

Authors:  B S Charak; R Agah; A Mazumder
Journal:  Blood       Date:  1993-06-15       Impact factor: 22.113

10.  Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo.

Authors:  P Paglia; C Chiodoni; M Rodolfo; M P Colombo
Journal:  J Exp Med       Date:  1996-01-01       Impact factor: 14.307

View more
  16 in total

1.  New developments in autologous tumor cell vaccination therapy for renal cell carcinoma.

Authors:  A J van den Eertwegh ; H M Pinedo
Journal:  Curr Oncol Rep       Date:  2000-09       Impact factor: 5.075

2.  Staphylococcus aureus agr and sarA functions are required for invasive infection but not inflammatory responses in the lung.

Authors:  Geoffrey Heyer; Shahryar Saba; Robert Adamo; William Rush; Grace Soong; Ambrose Cheung; Alice Prince
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

3.  Effects of granulocyte-macrophage colony stimulating factor (GM-CSF) in vivo on cytokine production and proliferation by spleen cells.

Authors:  S Khatami; E Brummer; D A Stevens
Journal:  Clin Exp Immunol       Date:  2001-08       Impact factor: 4.330

4.  Granulocyte-macrophage colony-stimulating factor-deficient mice have impaired resistance to blood-stage malaria.

Authors:  J Riopel; M Tam; K Mohan; M W Marino; M M Stevenson
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

5.  Rabies virus expressing dendritic cell-activating molecules enhances the innate and adaptive immune response to vaccination.

Authors:  Yongjun Wen; Hualei Wang; Hua Wu; Fuhe Yang; Ralph A Tripp; Robert J Hogan; Zhen F Fu
Journal:  J Virol       Date:  2010-11-24       Impact factor: 5.103

6.  Post-transcriptional Regulation of NK Cell Activation.

Authors:  Tae-Don Kim; Ju Yeong Park; Inpyo Choi
Journal:  Immune Netw       Date:  2009-08-31       Impact factor: 6.303

7.  Addition of GM-CSF to trastuzumab stabilises disease in trastuzumab-resistant HER2+ metastatic breast cancer patients.

Authors:  Y C Cheng; V Valero; M L Davis; M C Green; A M Gonzalez-Angulo; R L Theriault; J L Murray; G N Hortobagyi; N T Ueno
Journal:  Br J Cancer       Date:  2010-09-28       Impact factor: 7.640

8.  Transgenic mice showing inflammation-inducible overexpression of granulocyte macrophage colony-stimulating factor.

Authors:  B Burke; A Pridmore; N Harraghy; A Collick; J Brown; T Mitchell
Journal:  Clin Diagn Lab Immunol       Date:  2004-05

9.  Selective early production of CCL20, or macrophage inflammatory protein 3alpha, by human mast cells in response to Pseudomonas aeruginosa.

Authors:  Tong-Jun Lin; Lauren H Maher; Kaede Gomi; Jeffrey D McCurdy; Rafael Garduno; Jean S Marshall
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

10.  Regulatory T cells induced by GM-CSF suppress ongoing experimental myasthenia gravis.

Authors:  Jian Rong Sheng; Liang Cheng Li; Balaji B Ganesh; Bellur S Prabhakar; Matthew N Meriggioli
Journal:  Clin Immunol       Date:  2008-05-27       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.